Condition: Sepsis and Septic Shock · Trauma · Sponsor: Anders Aneman
Blood coagulation disorders are often seen in critically ill patients e.g. with severe infection or following extensive injury, that can lead to life threatening events as a result of excessive blood clot formation leading to organ failure. This study aims to use Viscoelastic Testing (VET) technology to detect patients at risk of excessive blood blot formation at the bedside, test new blood coagulation drugs, and guide life-saving use of blood modifying treatments.
This description comes directly from the study's public registry record.
Anders Aneman, MD, PhD, EDIC, FCICM · +61427915693 · anders.aneman@health.nsw.gov.au
Lucy Coupland, Nurs Cert, BSci (hons), PhD · +61419723330 · lucy.coupland@health.nsw.gov.au
Always discuss trial participation with your own doctor first.
| The Canberra hospital (ICU) | Canberra, Australian Capital Territory, Australia | Recruiting |
| Liverpool Hospital (ICU) | Liverpool, New South Wales, Australia | Recruiting |
| Macquarie University Hospital (ICU) | Macquarie, New South Wales, Australia | Recruiting |
| Royal North Shore Hospital (ICU) | St Leonards, New South Wales, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06680180